Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
† Study has passed its completion date and status has not been verified in more than two years.